307 related articles for article (PubMed ID: 26388542)
21. [An autopsied case of progressive supranuclear palsy presenting with slow progression and unusually prolonged disease duration].
Iwasaki Y; Mori K; Ito M; Mimuro M; Yoshida M
Rinsho Shinkeigaku; 2012; 52(3):156-60. PubMed ID: 22453039
[TBL] [Abstract][Full Text] [Related]
22. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
23. Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.
Desai Bradaric B; Patel A; Schneider JA; Carvey PM; Hendey B
J Neural Transm (Vienna); 2012 Jan; 119(1):59-71. PubMed ID: 21748523
[TBL] [Abstract][Full Text] [Related]
24. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
[TBL] [Abstract][Full Text] [Related]
25. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Caparros-Lefebvre D; Sergeant N; Lees A; Camuzat A; Daniel S; Lannuzel A; Brice A; Tolosa E; Delacourte A; Duyckaerts C
Brain; 2002 Apr; 125(Pt 4):801-11. PubMed ID: 11912113
[TBL] [Abstract][Full Text] [Related]
26. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
27. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
Nagao S; Yokota O; Nanba R; Takata H; Haraguchi T; Ishizu H; Ikeda C; Takeda N; Oshima E; Sakane K; Terada S; Ihara Y; Uchitomi Y
J Neurol Sci; 2012 Dec; 323(1-2):147-53. PubMed ID: 23026537
[TBL] [Abstract][Full Text] [Related]
28. Discriminating features of gait performance in progressive supranuclear palsy.
Amano S; Skinner JW; Lee HK; Stegemöller EL; Hack N; Akbar U; Vaillancourt D; McFarland NR; Hass CJ
Parkinsonism Relat Disord; 2015 Aug; 21(8):888-93. PubMed ID: 26032992
[TBL] [Abstract][Full Text] [Related]
29. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
[TBL] [Abstract][Full Text] [Related]
30. Mixed multiple system atrophy and progressive supranuclear palsy: a clinical and pathological report of one case.
Takanashi M; Ohta S; Matsuoka S; Mori H; Mizuno Y
Acta Neuropathol; 2002 Jan; 103(1):82-7. PubMed ID: 11837750
[TBL] [Abstract][Full Text] [Related]
31. [An 81-year-old woman with progressive motor disturbance, extrapyramidal features, dementia, and oculomotor palsy].
Urabe T; Mori H; Sumino S; Miwa H; Wakiya M; Shirai T; Takubo H; Mizuno Y
No To Shinkei; 1998 Mar; 50(3):291-301. PubMed ID: 9566008
[TBL] [Abstract][Full Text] [Related]
32. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
[TBL] [Abstract][Full Text] [Related]
33. Coexistence of PSP and MSA: a case report and review of the literature.
Uchikado H; DelleDonne A; Uitti R; Dickson DW
Acta Neuropathol; 2006 Feb; 111(2):186-92. PubMed ID: 16456665
[TBL] [Abstract][Full Text] [Related]
34. Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: a case of akinesia as a predominant feature of parkinsonism.
Yamamoto T; Kawamura J; Hashimoto S; Nakamura M; Iwamoto H; Kobashi Y; Ichijima K
J Neurol Sci; 1991 Jan; 101(1):98-106. PubMed ID: 1709202
[TBL] [Abstract][Full Text] [Related]
35. Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Rivest J; Quinn N; Marsden CD
Neurology; 1990 Oct; 40(10):1571-8. PubMed ID: 2215950
[TBL] [Abstract][Full Text] [Related]
36. Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes.
Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Antoni S; Ferger D; Reichmann H; Wilhelm H; Berg D; Ziemssen T
Mov Disord; 2007 Oct; 22(14):2123-6. PubMed ID: 17853484
[TBL] [Abstract][Full Text] [Related]
37. Parkinson's disease associated with argyrophilic grains clinically resembling progressive supranuclear palsy: an autopsy case.
Seno H; Kobayashi S; Inagaki T; Yamamori C; Miyaoka T; Horiguchi J; Wada M; Harada T
J Neurol Sci; 2000 Sep; 178(1):70-4. PubMed ID: 11018253
[TBL] [Abstract][Full Text] [Related]
38. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
Cordato NJ; Halliday GM; Harding AJ; Hely MA; Morris JG
Ann Neurol; 2000 Jun; 47(6):718-28. PubMed ID: 10852537
[TBL] [Abstract][Full Text] [Related]
39. Dual pathology of corticobasal degeneration and Parkinson's disease in a patient with clinical features of progressive supranuclear palsy.
Mooney T; Tampiyappa A; Robertson T; Grimley R; Burke C; Ng K; Patrikios P
Neurol India; 2011; 59(6):887-90. PubMed ID: 22234205
[TBL] [Abstract][Full Text] [Related]
40. [An autopsy case of postencephalitic parkinsonism: investigation on neurofibrillary tangles in comparison with those in progressive supranuclear palsy].
Mori H; Yoshimura M; Mizutani T; Kuzuhara S; Yamanouchi H; Shimada H; Tomonaga M
No To Shinkei; 1990 Jun; 42(6):553-9. PubMed ID: 2169789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
